Warfarin embryopathy: Balancing maternal and fetal risks with anticoagulation therapy

A male baby weighing 3170  g was born to a 21-year-old woman (gravida 2, para 0) at 39 weeks of gestation. The mother had a history of rheumatic heart disease with mechanical mitral valve replacement, and she was receiving warfarin for thrombotic prophylaxis. She had a complicated first pregnancy, with transient ischemic at tack at 23 weeks of gestation, which resulted in miscarriage, while she was receiving low molecular weight heparin (LMWH) anticoagulation with the dose adjusted according to the anti-factor Xa level.
Source: Pediatrics and Neonatology - Category: Perinatology & Neonatology Authors: Tags: Images Source Type: research